Latest Prostate-specific antigen Stories
-- High calibre German consulting company appointed to assist CE Mark registration process SYDNEY, May 27, 2014 /PRNewswire/ -- Australian biotechnology company Minomic International
Panel discusses long-term effect on quality of life ORLANDO, Fla., May 17, 2014 /PRNewswire-USNewswire/ -- A series of studies evaluating the outcomes, benefits, concerns and quality of life
Beckman Coulter's Prostate Health Index (phi) Available Nationwide for Better Prostate Cancer Detection BREA, Calif., April 24, 2014 /PRNewswire/ -- Beckman Coulter Diagnostics, a
The presence of chronic inflammation in benign prostate tissue was associated with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels.
Phase III Trial Now Recruiting Patients SANTA ROSA, Calif., April 15, 2014 /PRNewswire/ -- A phase III clinical trial conducted at the Meir Medical Center in Kfar-Saba, Israel is now
-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International
HOUSTON, April 7, 2014 /PRNewswire/ -- C4 Imaging LLC is pleased to announce the first patient implant with Sirius(TM), its novel positive-signal MRI Marker.
NORWALK, Conn., March 24, 2014 /PRNewswire/ -- UBM Medica US announces that Cancer Network, the online
Very small sample-size study incapable of showing cause-and-effect relationship WASHINGTON, March 3, 2014 /PRNewswire-USNewswire/ -- The American Chemistry Council (ACC) offers
New prostate cancer screening option combines existing tests to substantially increase accuracy CHICAGO, Feb.
- A serpent whose bite was fabled to produce intense thirst.